Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Annweiler

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 1990
[A low-cost localization technique for high-dose-rate afterloading applicators]G Albrecht, A Annweiler, H Sack
Nucleic Acids Research|October 11, 1994
Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoformsA Annweiler, S Zwilling, T Wirth
Nucleic Acids Research|May 11, 1994
The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBPS Zwilling, A Annweiler, T Wirth
Nucleic Acids Research|April 11, 1992
Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic miceA Annweiler, U Müller, T Wirth
Molecular and Cellular Biology|July 1, 1992
Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activityA Annweiler, M Müller-Immerglück, T Wirth
Nucleic Acids Research|July 11, 1991
A strategy for efficient in vitro translation of cDNAs using the rabbit beta-globin leader sequenceA Annweiler, R A Hipskind, T Wirth
The Journal of Biological Chemistry|February 5, 1993
Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free systemA Annweiler, S Zwilling, R A Hipskind, et al.
Immunobiology|July 1, 1995
Molecular principles of Oct2-mediated gene activation in B cellsT Wirth, P Pfisterer, A Annweiler, et al.
Nucleic Acids Research|January 11, 1991
Multiple Oct2 isoforms are generated by alternative splicingT Wirth, A Priess, A Annweiler, et al.
The EMBO Journal|April 1, 1994
Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activitiesP Pfisterer, A Annweiler, C Ullmer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 1990
[A low-cost localization technique for high-dose-rate afterloading applicators]G Albrecht, A Annweiler, H Sack
Nucleic Acids Research|October 11, 1994
Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoformsA Annweiler, S Zwilling, T Wirth
Nucleic Acids Research|May 11, 1994
The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBPS Zwilling, A Annweiler, T Wirth
Nucleic Acids Research|April 11, 1992
Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic miceA Annweiler, U Müller, T Wirth
Molecular and Cellular Biology|July 1, 1992
Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activityA Annweiler, M Müller-Immerglück, T Wirth
Nucleic Acids Research|July 11, 1991
A strategy for efficient in vitro translation of cDNAs using the rabbit beta-globin leader sequenceA Annweiler, R A Hipskind, T Wirth
The Journal of Biological Chemistry|February 5, 1993
Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free systemA Annweiler, S Zwilling, R A Hipskind, et al.
Immunobiology|July 1, 1995
Molecular principles of Oct2-mediated gene activation in B cellsT Wirth, P Pfisterer, A Annweiler, et al.
Nucleic Acids Research|January 11, 1991
Multiple Oct2 isoforms are generated by alternative splicingT Wirth, A Priess, A Annweiler, et al.
The EMBO Journal|April 1, 1994
Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activitiesP Pfisterer, A Annweiler, C Ullmer, et al.
Pageof 2